微生物群
免疫系统
生物
拟杆菌
粪便
肠道菌群
肠道微生物群
葡萄糖稳态
免疫学
内分泌学
生理学
内科学
糖尿病
微生物学
生物信息学
遗传学
医学
细菌
胰岛素抵抗
作者
P.K. Vaddi,Katharine A. Young,Molly Easter,Cristal M. Hill
标识
DOI:10.1093/geroni/igae098.3666
摘要
Abstract Introduction Studies on the gut-brain axis report that changes in the microbiome contribute to age-related diseases. One of the most significant factors affecting microbiome composition is diet. Prior work from our lab has demonstrated that low protein (LP) diets induce fibroblast growth factor 21, improve metabolic health, and extend lifespan in male mice. However, the molecular adaptations of a low-protein diet on gut health and their systemic effects on protecting against age-related diseases remains unclear. Here, we investigated the impact of an LP diet on the microbiome and the associated effects on metabolic and immune health. Methods At 15 months of age, female mice (n=12 mice/diet) were fed either a normal protein (NP) or LP diet for 20-weeks. Feces were collected to assess microbiota, species richness, and species diversity. Metabolic profiling on food intake, fasted glucose levels, and glucose tolerance tests were conducted to assess the relationship between microbiome profiles and metabolic health. Results Relative abundances of Bacteroides and Defferibacterota were reduced in LP diets and increased in Verrucomicrobiota. Gene set enrichment analyses (GSEA) reveal that mice on the LP diets regulate T-Cell dependent immune and inflammatory pathways. Consistent with our previous studies in male mice, we show that aging female have improved glucose clearance during LP-diet. Conclusion Notably, previous studies show Bacteroides species promote T-Cell dependent immune pathways, and Verrucomicrobiota species regulate glucose homeostasis. Collectively, GSEA data, the improvements in glucose homeostasis, and changes in microbiota significantly benefit metabolic and immune health.
科研通智能强力驱动
Strongly Powered by AbleSci AI